MarketWatch digs into nine blank-check companies that could be on the cusp of making big moves. The write-ups are intended to be put on a watch list. They’re based, in part, on acquisition speculation. And just like rumors of a merger or buyout in a conventional stock can ultimately come to nothing, SPAC investors should take all the hype and forecasting with a grain of salt until they see a press release announcing that the checks have been signed and these are done deals. Read more.
Related Posts
First SPAC set up Under New UK Rules to Close After Failing to Find Merger Target
Hambro Perks Acquisition said in a statement that it had ceased all operations except for the purposes of winding up the company and returning money to shareholders.
Mountain Crest Faces Lawsuit Over Better Therapeutics SPAC Deal
The SPAC's shareholderrs approved the deal in October 2021. At that time, shares were trading around $9.30. Better Therapeutics closed today at $1.13, down 2.59%.
Ex-L Catterton Asia Chief Thakran Said to Explore Singapore SPAC: Report
The blank-check firm could raise about $221 million.
SPACs Forced to Fund Deals with More Expensive Financing: Report
everal companies that recently announced plans to go public by merging with a SPAC have raised cash to fund the deals by issuing convertible bonds.